Examining Factors Associated With Medication Adherence in Youth With Bipolar Disorder.


Journal

JAACAP open
ISSN: 2949-7329
Titre abrégé: JAACAP Open
Pays: United States
ID NLM: 9918627288306676

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 1 9 2023
pubmed: 1 9 2023
entrez: 9 10 2024
Statut: ppublish

Résumé

To assess medication adherence and factors associated with poor adherence in youth with bipolar disorder (BD) followed from adolescence through young adulthood. Participants with BD recruited through the Course and Outcome of Bipolar Youth (COBY) study were included in this study if they were prescribed psychotropic medications and had at least 3 follow-up assessments of medication adherence (N= 179, ages 12-36). Medication adherence had been evaluated for a median of 8 years using a questionnaire derived from the Coronary Artery Risk Development in Young Adults (CARDIA) study. For the longitudinal evaluation, adherence was measured as the percentage of follow-up assessments in which the participants did not endorse any of the nonadherence items included in the questionnaire. Concurrent and future predictors of poor adherence were assessed using both univariate and multivariate longitudinal analyses. Among the participants, 51% reported poor adherence in more than 50% of their follow-up assessments. Younger age, family conflicts, polypharmacy, lower functioning, greater severity of mood symptoms, and comorbid disorders were associated with poor adherence in the univariate analyses. In the multivariate analyses, comorbid ADHD was the single most influential factor associated with concurrent and future poor adherence in all age groups. Participants' most reported reasons for poor adherence were forgetfulness (56%), negative attitudes toward medication treatment (10.5%), and disturbed daily routine (7%). Poor medication adherence is a significant problem in youth with BD with the most influential factor being the presence of comorbid ADHD. Thus, it is important to identify and appropriately treat comorbid ADHD to improve medication adherence and patients' prognosis. Providers should also recommend tools to enhance consistent medication intake and address patients' concerns and negative beliefs about their illness and treatment.

Identifiants

pubmed: 39381188
doi: 10.1016/j.jaacop.2023.06.001
pmc: PMC11460791
doi:

Types de publication

Journal Article

Langues

eng

Pagination

105-115

Auteurs

Mohamed Y Elhosary (MY)

UPMC Western Psychiatric Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania.

John A Merranko (JA)

UPMC Western Psychiatric Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania.

Tina R Goldstein (TR)

UPMC Western Psychiatric Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania.

Danella M Hafeman (DM)

UPMC Western Psychiatric Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania.

Benjamin I Goldstein (BI)

Centre for Youth Bipolar Disorder, Centre for Addiction and Mental Health, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.

Mary Kay Gill (MK)

UPMC Western Psychiatric Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania.

Heather Hower (H)

Warren Alpert Medical School of Brown University, Providence, Rhode Island.

David A Axelson (DA)

Nationwide Children's Hospital, and The Ohio State College of Medicine, Columbus, Ohio.

Jeffrey I Hunt (JI)

Warren Alpert Medical School of Brown University, Providence, Rhode Island.

Shirley Yen (S)

Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Massachusetts Mental Health Center and Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Rasim Somer Diler (RS)

UPMC Western Psychiatric Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania.

Neal D Ryan (ND)

UPMC Western Psychiatric Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania.

Martin B Keller (MB)

Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Miller School of Medicine at the University of Miami, Miami, FL.

Lauren M Weinstock (LM)

Warren Alpert Medical School of Brown University, Providence, Rhode Island.

Michael Strober (M)

David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.

Boris Birmaher (B)

UPMC Western Psychiatric Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania.

Classifications MeSH